J&J COVID Booster Vaccine Yanzu Ya Samu Koren Haske

A KYAUTA Kyauta 8 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Johnson & Johnson sun ba da sanarwar cewa Kwamitin Ba da Shawara kan Cibiyoyin Kula da Cututtuka na Amurka (CDC) Kwamitin Ba da Shawara kan Ayyuka na rigakafi (ACIP), ya ba da shawarar allurar rigakafin ta COVID-19 a matsayin abin ƙarfafawa ga duk mutanen da suka cancanci samun allurar COVID-19 da aka ba da izini.

<

           

Paul Stoffels, MD, Mataimakin Shugaban Kwamitin Zartarwa da Babban Jami'in Kimiyya a Johnson da Johnson. “Allurar Johnson & Johnson ta ba da kariya ta kashi 19 a cikin Amurka daga COVID-94 lokacin da aka ba shi azaman mai ƙarfafawa bayan allurar Johnson & Johnson guda ɗaya, kuma saboda keɓaɓɓen tsarin aikin sa, yana ba da kariya mai dorewa, mai dorewa. Muna da kwarin gwiwa kan fa'idar da za ta bayar ga miliyoyin mutane a duniya. "

An ba da shawarar rigakafin Johnson & Johnson COVID-19 a matsayin mai ƙarfafawa ga manya masu shekaru 18 da haihuwa waɗanda suka karɓi allurar harbi ɗaya na Johnson & Johnson aƙalla watanni biyu da suka gabata. An kuma ba da shawarar ƙarin kashi na rigakafin Johnson & Johnson COVID-19 ga manya waɗanda suka cancanta aƙalla watanni shida bayan kashi na biyu na rigakafin mRNA da aka ba da izini.

An tura shawarar ACIP ga Daraktan CDC da Ma'aikatar Lafiya da Ayyukan Dan Adam (HHS) don dubawa da kuma karba.

Allurar COVID-19 guda ɗaya ta Kamfanin ta karɓi Izinin Amfani da Gaggawa na FDA ga tsofaffi masu shekaru 18 da haihuwa a ranar 27 ga Fabrairu, 2021. A ranar 20 ga Oktoba, 2021, FDA ta ba da izini don amfani da gaggawa ta amfani da allurar rigakafin Johnson & Johnson COVID-19. ga tsofaffi masu shekaru 18 da tsufa aƙalla watanni biyu bayan allurar farko tare da allurar rigakafi ta Kamfani guda.

Amfani da Izini

An ba da izinin allurar rigakafin Janssen COVID-19 don amfani a ƙarƙashin Izinin Amfani da Gaggawa (EUA) don allurar rigakafin cutar don hana Cutar Coronavirus 2019 (COVID-19) wanda cutar sankarau mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2) ta haifar:

• Tsarin allurar riga-kafi na Janssen COVID-19 Alurar riga-kafi ɗaya ce (0.5 ml) da ake gudanarwa ga mutane masu shekaru 18 da haihuwa.

• Janssen COVID-19 guda ɗaya na ƙarar maganin rigakafi (0.5 ml) ana iya ba da shi aƙalla watanni 2 bayan rigakafin farko ga mutane masu shekaru 18 da haihuwa.

• Za a iya yin amfani da allurar rigakafi guda ɗaya na Janssen COVID-19 Vaccine (0.5 mL) azaman maganin ƙaruwa daban-daban bayan kammala allurar rigakafi ta farko tare da wani allurar rigakafin COVID-19 da aka amince da shi. Yawan mutanen da suka cancanta da tazarar dosing don ƙimar ƙaruwa na heterologous iri ɗaya ne da waɗanda aka ba da izini don ƙara yawan allurar rigakafin da aka yi amfani da ita don allurar rigakafi ta farko.

MUHIMMAN BAYANI AKAN KIYAYYA

ME YA KAMATA KA AMBACI GA MAI BARKA DA ALLURAR KUWA KAFIN KA SAMU ALLURAR COVID-19 JANSSEN?

Faɗa wa mai bada alurar riga kafi game da duk yanayin lafiyar ku, gami da idan kun:

• suna da duk wani rashin lafiyan halayen

• zazzabi

• suna da matsalar zubar jini ko kuma suna kan mai rage jini

• suna da rigakafi ko kuma suna kan maganin da ke shafar tsarin garkuwar jikin ku

• suna da ciki ko shirin yin ciki

• suna shayarwa

• sun sami wani maganin COVID-19

• sun taɓa suma tare da allura

WAYE YA KAMATA YA SAMU JANSSEN COVID-19 VACCINE?

Bai kamata ku sami Janssen COVID-19 Vaccine ba idan kun:

• ya yi mummunan rashin lafiyan bayan allurar baya ta wannan allurar

• ya kamu da rashin lafiya mai tsanani ga kowane sinadari na wannan maganin.

TA YAYA AKE BA JANSSEN COVID-19 VACCINE?

Za a ba ku Allurar Janssen COVID-19 a matsayin allura a cikin tsoka. 

Allurar Farko: Ana gudanar da allurar Janssen COVID-19 azaman kashi ɗaya.

Adadin Ƙarfafawa:

Za'a iya yin allurar rigakafi guda ɗaya na Janssen COVID-19 aƙalla watanni biyu bayan rigakafin farko tare da Janssen COVID-19 Vaccine.

• Za a iya amfani da allurar rigakafi guda ɗaya na Janssen COVID-19 Vaccine ga mutanen da suka cancanta waɗanda suka gama allurar riga-kafi tare da allurar COVID-19 daban da aka ba da izini ko ta amince. Da fatan za a bincika tare da mai ba da sabis na kiwon lafiya dangane da cancanta da kuma lokacin ƙimar ƙarfafawa.

MENENE HADARIN ALJANIN COVID-19 JANSSEN?

Illolin da aka ruwaito tare da Janssen COVID-19 Vaccine sun haɗa da:

• Hanyoyin shafin allura: zafi, jajayen fata, da kumburi.

• Illolin gaba ɗaya: ciwon kai, jin kasala sosai, ciwon tsoka, tashin zuciya, zazzabi.

• Kumburi na lymph nodes.

• Jinin jini.

• Jin daɗi da ba a saba gani ba a cikin fata (kamar tingling ko jiɓin jijiya) (paresthesia), raguwar ji ko ƙima, musamman a cikin fata (hypoesthesia).

• Ringi mai dagewa a cikin kunnuwa (tinnitus).

• Zawo, amai.

Matsanancin Maganin Allergic

Akwai dama mai nisa cewa rigakafin Janssen COVID-19 na iya haifar da mummunan rashin lafiyan. Muguwar rashin lafiyan yakan faru a cikin 'yan mintoci kaɗan zuwa awa ɗaya bayan samun allurar Janssen COVID-19. Don haka, mai ba da rigakafin ku na iya tambayar ku da ku zauna a wurin da kuka karɓi maganin ku don saka idanu bayan rigakafin. Alamomin rashin lafiyar mai tsanani na iya haɗawa da:

• Wahalar numfashi

• Fuskar fuskarka da makogwaro

• bugun zuciya mai sauri

• Mummunan kurji a jikinka

• Dizziness da rauni

Jini na jini tare da ƙananan matakan platelets

Ruwan jini da ya shafi tasoshin jini a cikin kwakwalwa, huhu, ciki, da ƙafafu tare da ƙananan matakan platelet (ƙwayoyin jinin da ke taimaka wa jikin ku daina zubar jini), sun faru a wasu mutanen da suka karɓi Allurar Janssen COVID-19. A cikin mutanen da suka haɓaka waɗannan ɗigon jini da ƙananan matakan platelet, alamun sun fara kusan mako ɗaya zuwa biyu bayan alurar riga kafi. Bayar da rahoton waɗannan dunƙulewar jini da ƙananan matakan platelet ya kasance mafi girma a cikin mata masu shekaru 18 zuwa 49. Damar samun wannan ta faru tana da nisa. Ya kamata ku nemi kulawar likita nan da nan idan kuna da ɗayan alamun da ke biye bayan samun Janssen COVID-19 Vaccine:

• Numfashin numfashi,

• Ciwon kirji,

• kumburin kafa,

• Ciwon ciki mai ɗorewa,

• Ciwon kai mai tsanani ko na ci gaba ko duhun gani.

• Sauƙaƙe rauni ko ƙananan ɗigon jini a ƙarƙashin fata bayan wurin allurar.

Waɗannan ƙila ba su zama duk illolin da ke tattare da rigakafin Janssen COVID-19 ba. Mummunan sakamako da ba zato ba tsammani na iya faruwa. Har yanzu ana nazarin rigakafin Janssen COVID-19 a gwajin asibiti.

Guillain Barré ciwo

Ciwon Guillain Barré (cuta ce ta jijiyoyin jiki wanda tsarin garkuwar jiki ke lalata ƙwayoyin jijiya, yana haifar da raunin tsoka kuma wani lokacin naƙasa) ya faru a wasu mutanen da suka karɓi Allurar Janssen COVID-19. A yawancin waɗannan mutanen, alamun sun fara a cikin kwanaki 42 bayan karɓar Janssen COVID-19 Vaccine. Damar samun wannan faruwar ta ragu sosai. Yakamata ku nemi kulawar likita nan da nan idan kun sami ɗayan alamun da ke biyo bayan karɓar Janssen COVID-19 Vaccine:

• Rauni ko raɗaɗi, musamman a ƙafafu ko hannaye, wanda ke daɗa muni da yaduwa zuwa wasu sassan jiki.

• Wahalar tafiya.

• Wahala da motsin fuska, gami da magana, taunawa, ko hadiyewa.

• Gani biyu ko rashin iya motsa idanu.

• Wahala tare da sarrafa mafitsara ko aikin hanji.

ME YA KAMATA NA YI GAME DA ILLOLIN GABA?

Idan kun fuskanci mummunan rashin lafiyan, kira 9-1-1, ko je asibiti mafi kusa.

Kira mai ba da rigakafin ko mai ba da lafiyar ku idan kuna da wasu illolin da ke damun ku ko kuma ba su tafi ba.

Bayar da illolin maganin rigakafi ga FDA/CDC Tsarin Ba da Rahoto Mara Kyau (VAERS). Lambar kyauta ta VAERS ita ce 1-800-822-7967 ko bayar da rahoto akan layi zuwa vaers.hhs.gov. Da fatan za a haɗa da "Janssen COVID-19 Vaccine EUA" a cikin layin farko na akwatin #18 na fam ɗin rahoton. Bugu da kari, zaku iya bayar da rahoton illa ga Janssen Biotech Inc. a 1-800-565-4008.

ZAN IYA SAMUN JANSSEN COVID-19 VACCINE A LOKACI DA SAURAN VACCINES?

Har yanzu ba a miƙa bayanai ga FDA kan gudanar da rigakafin Janssen COVID-19 a lokaci guda da sauran alluran rigakafi ba. Idan kuna tunanin karɓar Janssen COVID-19 Vaccine tare da wasu alluran rigakafi, tattauna zaɓin ku tare da mai ba da lafiya.

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

  • The eligible population(s) and dosing interval for the heterologous booster dose are the same as those authorized for a booster dose of the vaccine used for primary vaccination.
  • A single booster dose of the Janssen COVID-19 Vaccine may be administered to eligible individuals who have completed primary vaccination with a different authorized or approved COVID-19 vaccine.
  • Za'a iya ba da kashi ɗaya mai ƙarfafawa na rigakafin Janssen COVID-19 aƙalla watanni biyu bayan rigakafin farko tare da Janssen COVID-19 Vaccine.

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...